Mycophenolate Mofetil in Minimal Change NephrosisALFRED, R; SOYIBO, A. K.West indian medical journal. 2010, Vol 59, Num 3, pp 330-331, issn 0043-3144, 2 p.Article

Mycophenolate mofetil in dermatologyORVIS, Alissa K; WESSON, Stanton K; BREZA, Thomas S et al.Journal of the American Academy of Dermatology. 2009, Vol 60, Num 2, pp 183-199, issn 0190-9622, 17 p.Article

Mycophenolate mofetil for ocular myastheniaCHAN, Jane W.Journal of neurology. 2008, Vol 255, Num 4, pp 510-513, issn 0340-5354, 4 p.Article

Mycophenolate mofetil : A decade of clinical experienceDANOVITCH, Gabriel M.Transplantation. 2005, Vol 80, Num 2, pp S272-S274, issn 0041-1337, SUPArticle

Syndrome de condensation anormale de la chromatine sous mycophénolate mofétil = Abnormal chromatin clumping syndrome in three transplanted patients tretead with mycophenolate mofetilSMADJA, D; LEMAIRE, P; ATKHEN, N et al.Annales de biologie clinique (Paris). 2003, Vol 61, Num 4, pp 463-465, issn 0003-3898, 3 p.Article

Design of a trial comparing sirolimus plus mycophenolate mofetil versus sirolimus plus cyclosporinePONTICELLI, C; TARANTINO, A; CIVATI, G et al.Transplantation proceedings. 2003, Vol 35, Num 3A, pp 62-63, issn 0041-1345, 2 p., SUPConference Paper

Mycophenolate mofetil may allow cyclosporine and steroid sparing in de novo heart transplant patientsHAMOUR, Iman M; LYSTER, Haifa S; BURKE, Margaret M et al.Transplantation. 2007, Vol 83, Num 5, pp 570-576, issn 0041-1337, 7 p.Article

Pemphigoïde anti-p200: rémission sous mycophénolate mofétil (Cellcept^®) = Anti-p200 pemphigoid: Remission under mycophenolate mofetil (Cellcept^®)RAFFIN, D; DELAPLACE, M; ROUSSEL, A et al.Annales de dermatologie et de vénéréologie. 2013, Vol 140, Num 12, pp 784-787, issn 0151-9638, 4 p.Article

Mycophenolate mofetil versus azathioprine therapy is associated with a significant protection against long-term renal allograft function deteriorationMETER-KRIESCHE, Herwig-Ulf; STEFFEN, Bettina J; HOCHBERG, Alan M et al.Transplantation. 2003, Vol 75, Num 8, pp 1341-1346, issn 0041-1337, 6 p.Conference Paper

Graft survival following living-donor renal transplantation: A comparison of tacrolimus and cyclosporine microemulsion with mycophenolate mofetil and steroidsBUNNAPRADIST, Suphamai; DASWANI, Adarsh; TAKEMOTO, Steven K et al.Transplantation. 2003, Vol 76, Num 1, pp 10-15, issn 0041-1337, 6 p.Article

Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: Results at 6 monthsGONWA, Thomas; MENDEZ, Robert; YANG, Harold C et al.Transplantation. 2003, Vol 75, Num 8, pp 1213-1220, issn 0041-1337, 8 p.Conference Paper

Neurosarcoïdose et mycophénolate mofétil = Neurosarcoidosis treated with mycophenolate mofetil : two casesCHAUSSENOT, A; BOURG, V; CHANALET, S et al.Revue neurologique (Paris). 2007, Vol 163, Num 4, pp 471-475, issn 0035-3787, 5 p.Article

Mycophenolate mofetil treatment in resistant myositisPISONI, C. N; CUADRADO, M. J; KHAMASHTA, M. A et al.Rheumatology (Oxford. Print). 2007, Vol 46, Num 3, pp 516-518, issn 1462-0324, 3 p.Article

Treatment of Mediastinal Fibrosis with Mycophenolate MofetilWITSCHI, Michael; GUGGER, Mathias; NICOD, Laurent P et al.Respiration (Basel). 2009, Vol 78, Num 3, pp 330-333, issn 0025-7931, 4 p.Article

Antiproliferative profile of sirolimus and mycophenolate mofetil : impact of the SI/MPL ratioVOISARD, Rainer; GECGÜNER, Levent; BAUR, Regine et al.International journal of cardiology. 2005, Vol 102, Num 3, pp 435-442, issn 0167-5273, 8 p.Article

Mycophenolate mofetil for lupus related myelopathyMOK, C. C; MAK, A; TO, C. H et al.Annals of the rheumatic diseases. 2006, Vol 65, Num 7, pp 971-973, issn 0003-4967, 3 p.Article

Mycophenolate Mofetil Impairs Transduction of Single-Stranded Adeno-Associated Viral VectorsMONTENEGRO-MIRANDA, Paula S; TEN BLOEMENDAAL, Lysbeth; KUNNE, Cindy et al.Human gene therapy. 2011, Vol 22, Num 5, pp 605-612, issn 1043-0342, 8 p.Article

Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver-transplant patients with renal dysfunctionCANTAROVICH, Marcelo; TZIMAS, George N; BARKUN, J et al.Transplantation. 2003, Vol 76, Num 1, pp 98-102, issn 0041-1337, 5 p.Article

Effectiveness and safety of mycophenolate mofetil as monotherapy in liver transplantationMORENO, J. M; RUBIO, E; GOMEZ, A et al.Transplantation proceedings. 2003, Vol 35, Num 5, pp 1874-1876, issn 0041-1345, 3 p.Conference Paper

Absence of an interaction between iron and mycophenolate mofetil absorptionDUCRAY, Patricia Sanwald; BANKEN, Ludger; GERBER, Marianne et al.British journal of clinical pharmacology. 2006, Vol 62, Num 4, pp 492-495, issn 0306-5251, 4 p.Article

Histological changes after the use of mycophenolate mofetil in autoimmune hepatitisBRUNT, Elizabeth M; DI BISCEGLIE, Adrian M.Human pathology. 2004, Vol 35, Num 4, pp 509-512, issn 0046-8177, 4 p.Article

Mycophenolate mofetil levels in stable kidney transplant recipientsFERNANDEZ, A; MARCEN, R; BURGOS, J et al.Transplantation proceedings. 2007, Vol 39, Num 7, pp 2182-2184, issn 0041-1345, 3 p.Conference Paper

Long-term benefit of mycophenolate mofetil in renal transplantationLANG, Philippe; PARDON, Agathe; AUDARD, Vincent et al.Transplantation. 2005, Vol 79, Num 3, pp S47-S48, issn 0041-1337, SUPConference Paper

Impact of mycophenolate mofetil loading on drug exposure in the early posttransplant periodKIBERD, B. A; PUTHENPARUMPIL, J. J; FRASER, A et al.Transplantation proceedings. 2005, Vol 37, Num 5, pp 2320-2323, issn 0041-1345, 4 p.Article

Mycophenolate mofetil in pediatric renal transplantationETTENGER, Robert; SARWAL, Minnie M.Transplantation. 2005, Vol 80, Num 2, pp S201-S210, issn 0041-1337, SUPArticle